ProCE Banner Activity

艾滋病抗病毒药物治疗及预防

聆听 HIV 专家论述中国 HIV 治疗的关键方面,包括一线治疗 ARV 选择、HIV 预防以及除一线治疗以外的治疗选择。

Released: May 14, 2021

Expiration: May 13, 2022

Share

Faculty

Zunyou Wu

Zunyou Wu, MD, PhD

Chief Epidemiologist, China CDC
Director, Division of HIV Prevention
NCAIDS/China CDC
Adjunct Professor of Epidemiology, UCLA
Beijing, China

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

由以下机构提供支持和教育补助金

ViiV Healthcare

Target Audience

此计划适用于为感染 HIV 的患者提供护理的中国医师和其他医疗保健服务提供者。

Learning Objectives

Upon completion of this activity, participants should be able to:
  • 应用国家指导原则为 HIV 患者选择合适的一线抗逆转录病毒疗法
  • 在需要时和适当的情况下,为经历病毒治疗失败的患者选择新的 ARV 方案
  • 根据可用数据和建议实施暴露前和暴露后的 HIV 预防

Faculty Disclosure

Primary Author

Zunyou Wu, MD, PhD

Chief Epidemiologist, China CDC
Director, Division of HIV Prevention
NCAIDS/China CDC
Adjunct Professor of Epidemiology, UCLA
Beijing, China

吴尊友,没有相关的利益冲突要报告

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

哲学博士 Jennifer M. Blanchette 没有相关的利益冲突要报告。

Edward King, M.A.

Vice President, Editorial
Clinical Care Options, LLC

文学硕士 Edward King 没有相关的利益冲突要报告。

Additional Information

Program Medium

This program has been made available online.

Participation in this self-study activity should be completed in approximately hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from May 14, 2021, through May 13, 2022:

1. Register online at httpProgram Medium

This program has been made available online.


Goal


这项活动通过聚焦HIV治疗领域的最新进展及诊所中遇到的关键问题,旨在加强临床医生解决HIV管理中最重要和最具挑战的问题的能力。

Goal


此活动的目的是通过用中文提供关于如何正确使用可用的抗逆转录病毒疗法(符合国家指导原则)的教育,提高参与者在中国管理感染 HIV 的患者的能力。